Cargando…

Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report

BACKGROUND: Machado-Joseph disease (MJD), or spinocerebellar ataxia type 3 (SCA3), is an autosomal dominant neurodegenerative disorder of late onset, which is caused by a CAG repeat expansion in the coding region of the ATXN3 gene. This disease presents clinical heterogeneity, which cannot be comple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bettencourt, Conceição, Santos, Cristina, Coutinho, Paula, Rizzu, Patrizia, Vasconcelos, João, Kay, Teresa, Cymbron, Teresa, Raposo, Mafalda, Heutink, Peter, Lima, Manuela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217914/ https://www.ncbi.nlm.nih.gov/pubmed/22023810 http://dx.doi.org/10.1186/1471-2377-11-131

Ejemplares similares

Nystagmus as an early ocular alteration in Machado-Joseph disease (MJD/SCA3)
por: Raposo, Mafalda, et al.
Publicado: (2014)

Tissue-Specific Vulnerability to Apoptosis in Machado-Joseph Disease
por: Ferreira, Ana F., et al.
Publicado: (2023)

Machado-Joseph Disease: from first descriptions to new perspectives
por: Bettencourt, Conceição, et al.
Publicado: (2011)

The Homogeneous Azorean Machado-Joseph Disease Cohort: Characterization and Contributions to Advances in Research
por: Lima, Manuela, et al.
Publicado: (2023)

MR Imaging of SCA3/MJD
por: Wan, Na, et al.
Publicado: (2020)

Profiling Microglia in a Mouse Model of Machado–Joseph Disease
por: Campos, Ana Bela, et al.
Publicado: (2022)

Genome-wide association study identifies genetic factors that modify age at onset in Machado-Joseph disease
por: Akçimen, Fulya, et al.
Publicado: (2020)

Cerebellar lncRNA Expression Profile Analysis of SCA3/MJD Mice
por: Long, Zhe, et al.
Publicado: (2018)

The longitudinal progression of MRI changes in pre-ataxic carriers of SCA3/MJD
por: de Oliveira, Camila Maria, et al.
Publicado: (2023)

Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease
por: Miranda, Catarina Oliveira, et al.
Publicado: (2022)

Trehalose alleviates the phenotype of Machado–Joseph disease mouse models
por: Santana, Magda M., et al.
Publicado: (2020)

Familial spontaneous pneumothorax and Machado–Joseph disease
por: Pelayo, Jerald, et al.
Publicado: (2020)

Cerebellar Rotation Abnormalities Observed in Machado-Joseph Disease
por: Nomura, Taichi, et al.
Publicado: (2020)

Gene-Related Cerebellar Neurodegeneration in SCA3/MJD: A Case-Controlled Imaging-Genetic Study
por: Peng, Huirong, et al.
Publicado: (2019)

Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment
por: Onofre, Isabel, et al.
Publicado: (2016)

T2-hyperintensity in the internal globus pallidus in Machado-Joseph disease
por: Meira, Alex T., et al.
Publicado: (2023)

Hsp104 Suppresses Polyglutamine-Induced Degeneration Post Onset in a Drosophila MJD/SCA3 Model
por: Cushman-Nick, Mimi, et al.
Publicado: (2013)

A Pipeline to Assess Disease-Associated Haplotypes in Repeat Expansion Disorders: The Example of MJD/SCA3 Locus
por: Costa, Inês P. D., et al.
Publicado: (2019)

Corrigendum: Gene-Related Cerebellar Neurodegeneration in SCA3/MJD: A Case-Controlled Imaging-Genetic Study
por: Peng, Huirong, et al.
Publicado: (2020)

Epigenetic Age Acceleration in Frontotemporal Lobar Degeneration: A Comprehensive Analysis in the Blood and Brain
por: Murthy, Megha, et al.
Publicado: (2023)

Clinical manifestations and gene mutation in a case of Machado-Joseph disease★
por: Zhang, Bin, et al.
Publicado: (2012)

State biomarkers for Machado Joseph disease: Validation, feasibility and responsiveness to change
por: Furtado, Gabriel Vasata, et al.
Publicado: (2019)

Machado-Joseph Deubiquitinases: From Cellular Functions to Potential Therapy Targets
por: Zeng, Chenming, et al.
Publicado: (2020)

Sentinel Node Biopsy and Lumpectomy in a Patient with Machado–Joseph Disease
por: Aldawoodi, N. N., et al.
Publicado: (2019)

Neuropeptide Y (NPY) intranasal delivery alleviates Machado–Joseph disease
por: Duarte-Neves, Joana, et al.
Publicado: (2021)

Analysis of the GGGGCC Repeat Expansions of the C9orf72 Gene in SCA3/MJD Patients from China
por: Wang, Chunrong, et al.
Publicado: (2015)

Ataxin-3 and Its E3 Partners: Implications for Machado–Joseph Disease
por: Durcan, Thomas M., et al.
Publicado: (2013)

Dystonia in Patients with Spinocerebellar Ataxia 3 - Machado-Joseph disease: An Underestimated Diagnosis?
por: Catai, Ligia Maria Perrucci, et al.
Publicado: (2018)

Is the High Frequency of Machado-Joseph Disease in China Due to New Mutational Origins?
por: Li, Tianjiao, et al.
Publicado: (2019)

What is the best way to keep walking and moving around for individuals with Machado-Joseph disease? A scoping review through the lens of Aboriginal families with Machado-Joseph disease in the Top End of Australia
por: Carr, Jennifer J, et al.
Publicado: (2019)

Two Novel SNPs in ATXN3 3’ UTR May Decrease Age at Onset of SCA3/MJD in Chinese Patients
por: Long, Zhe, et al.
Publicado: (2015)

Polyglutamine-expanded ataxin3 alter specific gene expressions through changing DNA methylation status in SCA3/MJD
por: Ding, Dongxue, et al.
Publicado: (2020)

Machado-Joseph disease in a Sudanese family links East Africa to Portuguese families and allows reestimation of ancestral age of the Machado lineage
por: Martins, Sandra, et al.
Publicado: (2023)

Familial hypercholesterolemia: Molecular characterization of possible cases from the Azores Islands (Portugal)
por: Cymbron, Teresa, et al.
Publicado: (2014)

High frequency of Machado-Joseph disease identified in Southeastern Chinese kindreds with spinocerebellar ataxia
por: Gan, Shi-Rui, et al.
Publicado: (2010)

Gabapentin for complex regional pain syndrome in Machado-Joseph disease: a case report
por: Lo, Yang-Ching, et al.
Publicado: (2011)

Neural correlates of ataxia severity in spinocerebellar ataxia type 3/Machado-Joseph disease
por: Hernandez-Castillo, Carlos R., et al.
Publicado: (2017)

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease
por: de Assis, Adriano M., et al.
Publicado: (2017)

Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease
por: Martier, Raygene, et al.
Publicado: (2019)

Remote Measurement of Functional Status in Pre-symptomatic and Symptomatic Individuals with Machado-Joseph Disease
por: Miglorini, Elaine Cristina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mj9ptnbati2bccos9ou9ef4dar